메뉴 건너뛰기




Volumn 61, Issue 1, 2007, Pages 17-23

An extractables/leachables strategy facilitated by collaboration between drug product vendors and plastic material/system suppliers

Author keywords

Extractables; Leachables; Vendor qualification

Indexed keywords

DRUG; PLASTIC;

EID: 33847624968     PISSN: 10797440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (13)

References (8)
  • 1
    • 33847642982 scopus 로고    scopus 로고
    • Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for Industry: Nasal Spray and Inhalation Solution, Suspension, and Nasal Spray Drug Products-Chemistry, Manufacturing and Controls Documentation. Section III.G. FDA: Rockville, MD, 2002.
    • Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for Industry: Nasal Spray and Inhalation Solution, Suspension, and Nasal Spray Drug Products-Chemistry, Manufacturing and Controls Documentation. Section III.G. FDA: Rockville, MD, 2002.
  • 2
    • 33847647767 scopus 로고    scopus 로고
    • Food and Drug Administration, Center for Drug Evaluation and Research. Draft Guidance for Industry: Metered Dose Inhaler (MDI) and Dry Powder (DPI) Drug Products-Chemistry, Manufacturing and Controls Documentation. Section III.G. FDA: Rockville, MD, 1998.
    • Food and Drug Administration, Center for Drug Evaluation and Research. Draft Guidance for Industry: Metered Dose Inhaler (MDI) and Dry Powder (DPI) Drug Products-Chemistry, Manufacturing and Controls Documentation. Section III.G. FDA: Rockville, MD, 1998.
  • 3
    • 33847664399 scopus 로고    scopus 로고
    • European Medicines Agency. EMEA/CVMP/205/04. Guideline on Plastic Immediate Packaging Materials. May 19, 2005.
    • European Medicines Agency. EMEA/CVMP/205/04. Guideline on Plastic Immediate Packaging Materials. May 19, 2005.
  • 4
    • 33847634519 scopus 로고    scopus 로고
    • Association for the Advancement of Medical Instrumentation (AAMI). ISO/FDIS 10993-17:2002. Biological Evaluation of Medical Devices-Part 17: Establishment of Allowable Limits for Leachables Substances. November 27, 2002.
    • Association for the Advancement of Medical Instrumentation (AAMI). ISO/FDIS 10993-17:2002. Biological Evaluation of Medical Devices-Part 17: Establishment of Allowable Limits for Leachables Substances. November 27, 2002.
  • 5
    • 33745658955 scopus 로고    scopus 로고
    • Application of modern analytical technologies to the identification of extractables and leachables
    • Norwood, D. L.; Nagao, L.; Lyapustina, S.; Munos, M. Application of modern analytical technologies to the identification of extractables and leachables. Am. Pharm. Rev. 2005, 78, 80, 82-87 .
    • (2005) Am. Pharm. Rev , vol.78 , Issue.80 , pp. 82-87
    • Norwood, D.L.1    Nagao, L.2    Lyapustina, S.3    Munos, M.4
  • 6
    • 0037356077 scopus 로고    scopus 로고
    • Nomenclature associated with the chemical characterization of, and compatibility evaluations for, medical product delivery systems
    • Jenke, D. R. Nomenclature associated with the chemical characterization of, and compatibility evaluations for, medical product delivery systems. PDA J. Pharm. Sci. Technol. 2003, 57 (2), 97-108.
    • (2003) PDA J. Pharm. Sci. Technol , vol.57 , Issue.2 , pp. 97-108
    • Jenke, D.R.1
  • 7
    • 25144493663 scopus 로고    scopus 로고
    • Linking extractables and leachables in container/closure applications
    • Jenke, D. R. Linking extractables and leachables in container/closure applications. PDA J. Pharm. Sci. Technol. 2005, 59 (4), 265-281.
    • (2005) PDA J. Pharm. Sci. Technol , vol.59 , Issue.4 , pp. 265-281
    • Jenke, D.R.1
  • 8
    • 33745654627 scopus 로고    scopus 로고
    • Developing a correlation between extractables & leachables in MDIs and DPIs
    • Hansen, K. J. Developing a correlation between extractables & leachables in MDIs and DPIs. Drug Delivery Technology 2005, 5, 66-68.
    • (2005) Drug Delivery Technology , vol.5 , pp. 66-68
    • Hansen, K.J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.